Teach me like neonatologist, paeditrcian in depth topic - Плесента. Formation of плесента. Functions of placenta, placental abnormalities.

Reading File

Finding Sources

Reading File

Loading Image

Reading File

Loading Image

Reading File

I now have comprehensive content from multiple authoritative textbooks. Let me compile the full in-depth teaching response.

The Placenta (Плацента) - A Complete Neonatologist/Paediatrician's Perspective

Sources Used

The Developing Human: Clinically Oriented Embryology (Moore & Persaud)
Histology: A Text and Atlas (Ross & Pawlina)
Robbins, Cotran & Kumar: Pathologic Basis of Disease
Creasy & Resnik's Maternal-Fetal Medicine

1. WHAT IS THE PLACENTA?

The placenta is a fetomaternal organ - it has two distinct components:

Fetal part - formed by the chorion (outermost fetal membrane derived from the chorionic sac)
Maternal part - formed by the decidua basalis (the endometrium directly beneath the implanted embryo)

At term, the placenta is disc-shaped, 15-20 cm in diameter, 2-3 cm thick, and weighs 500-600 g - approximately one-sixth the weight of the fetus.

2. FORMATION OF THE PLACENTA

2.1 The Decidua - First Step

When the blastocyst implants, the endometrium transforms into the decidua. Three regions are named by their relationship to the implantation site:

Region	Location	Role
Decidua basalis	Deep to the conceptus	Forms the maternal part of the placenta
Decidua capsularis	Superficial, overlying the conceptus	Disappears as pregnancy advances
Decidua parietalis	All remaining endometrium	Lines the rest of the uterine cavity

In response to rising progesterone, connective tissue cells enlarge to form decidual cells packed with glycogen and lipids. The decidual reaction (cellular and vascular changes at implantation) provides nutrition for the early embryo.

2.2 Trophoblast Invasion and the Lacunar Stage (Week 2)

Around day 9 after fertilization, the syncytiotrophoblast erodes maternal capillaries forming trophoblastic lacunae (blood-filled spaces). Maternal sinusoids anastomose with these lacunae, establishing a primitive uteroplacental circulation - driven by arteriovenous pressure differentials. Numerous pinocytotic vesicles in the syncytiotrophoblast allow transfer of nutrients to the embryo.

This is the era of hemotrophic nutrition (via maternal blood) replacing the earlier histiotrophic nutrition (via decidual cell breakdown products).

2.3 Chorionic Villi Development - The Core of Placentation

This is the most important structural event in placental formation:

Development of chorionic villi - primary, secondary, tertiary stages

Primary villi (end of Week 2)

Syncytiotrophoblast + cytotrophoblast form finger-like projections into the decidua
No mesenchyme or vessels yet

Secondary villi (early Week 3)

Extraembryonic mesenchyme (connective tissue) grows into the villi core
Still surrounded by cytotrophoblast and syncytiotrophoblast

Tertiary villi (late Week 3)

Blood vessels and supportive cells (including Hofbauer cells - placental macrophages) differentiate within the mesenchymal core
Fetal blood vessels now form; this is functional vasculogenesis

Maturation during pregnancy:

Early pregnancy: Large, edematous villi, few vessels, many connective tissue cells, thick syncytiotrophoblast + continuous cytotrophoblast layer
Late pregnancy: Cytotrophoblast becomes discontinuous, syncytiotrophoblast nuclei aggregate into syncytial knots, more fetal blood vessels, less cellular stroma

2.4 The Cytotrophoblastic Shell and EVT Invasion

A key event: cytotrophoblast cells break out from anchoring villi and form:

Cytotrophoblastic shell - continuous cell layer separating decidua from maternal blood sinuses
Interstitial trophoblast - cells dispersed within decidua
Endovascular trophoblast (EVT) - adopts an endothelial phenotype, invades and remodels the spiral arteries, replacing their tunica media and endothelium, converting them into wide, low-resistance, high-flow channels

This arterial remodeling is physiologically critical: it ensures stable, high-flow perfusion of the intervillous space regardless of maternal vasoactive molecules. Inadequate EVT invasion → poor perfusion → preeclampsia and fetal growth restriction (FGR).

2.5 Chorion Frondosum vs. Chorion Laeve

As the chorionic sac grows:

Chorion frondosum ("leafy chorion"): villi adjacent to the decidua basalis - proliferate vigorously to form the fetal placenta
Chorion laeve ("smooth chorion"): villi on the side facing the decidua capsularis - degenerate and disappear as blood supply diminishes

The amniotic sac expands rapidly, fusing the amnion with the chorion laeve to form the amniochorionic membrane - the bag of waters that ruptures during labor.

2.6 Final Architecture at Full Term

Placental circulation - Day 16 vs Day 21 embryo

The definitive placenta is organized into 15-30 cotyledons, each consisting of a main stem villus (truncus chorii) with many branch villi. Cotyledons are separated by placental septa projecting from the basal plate. The intervillous space is bathed by maternal arterial blood (600 mL/min at term) via 80-100 spiral arteries.

3. PLACENTAL CIRCULATION

3.1 Fetal Circulation

Deoxygenated blood: fetus → umbilical arteries (2) → divide at placental surface → chorionic arteries → chorionic villi capillaries
Oxygenated blood: thin-walled veins → converge → umbilical vein (1) → fetus
No intermingling of fetal and maternal blood under normal conditions (microscopic breaks can allow feto-maternal hemorrhage)

3.2 Maternal Circulation

Maternal blood enters the intervillous space through spiral arteries as high-pressure jets, circulates around the villi, then returns via endometrial veins. The entire intervillous space turns over approximately 3-4 times per minute.

3.3 The Placental Membrane (Placental Barrier)

Four layers separate fetal from maternal blood (early pregnancy):

Syncytiotrophoblast
Cytotrophoblast
Connective tissue (mesenchyme)
Fetal capillary endothelium

In late pregnancy, cytotrophoblast thins out, reducing this to 2-3 layers, which increases exchange efficiency. This thinning is critical for late-gestation gas and nutrient transfer.

4. FUNCTIONS OF THE PLACENTA

4.1 Respiratory Function (Gas Exchange)

O₂, CO₂, carbon monoxide - all by simple diffusion
O₂ transport is flow-limited, not diffusion-limited → fetal hypoxia results from reduced uterine or fetal blood flow, not from diffusion failure
Fetal hemoglobin (HbF) has higher O₂ affinity than adult HbA → facilitates O₂ loading from maternal blood
Placental efficiency for gas exchange approaches that of the lungs

4.2 Nutritional Function

Substance	Transport Mechanism
Water	Simple diffusion (increasing amounts with advancing gestational age)
Glucose	Facilitated diffusion via GLUT-1 (insulin-independent)
Amino acids	Active transport (fetal levels exceed maternal levels)
Free fatty acids	Simple diffusion (long-chain PUFAs in highest amounts)
Vitamins	Cross by diffusion
Iron	Active transport via transferrin receptors
Cholesterol, triglycerides, phospholipids	Transferred from maternal side

Clinical note: Glucose is the primary fetal energy substrate. Any impairment of GLUT-1 or reduced maternal glucose availability directly affects fetal growth.

4.3 Excretory Function

Fetal waste products transferred to maternal blood for elimination:

CO₂, water, urea, uric acid, bilirubin → maternal kidneys and lungs excrete them
Bilirubin in particular is important: the fetus cannot conjugate bilirubin efficiently, so unconjugated bilirubin crosses to the mother for hepatic clearance. This is why severe hyperbilirubinemia does not accumulate prenatally.

4.4 Protective (Barrier) Function

Substances that DO NOT cross:

Bacteria (in most cases)
Heparin
IgS (large molecules)
IgM (does not cross the placenta - important clinically: elevated IgM in cord blood = congenital infection)

Substances that DO cross:

IgG - actively transported (neonatal passive immunity; peaks at term)
Drugs (most cross by diffusion - clinically vital: opioids, sedatives, alcohol, cocaine)
Viruses (CMV, rubella, herpes, varicella, HIV)
Toxoplasma gondii, Treponema pallidum

Clinical pearl: IgG transfer is the basis for neonatal passive immunity. Premature infants have low IgG (transfer is highest in the 3rd trimester, especially after 32 weeks), making them more susceptible to infection.

4.5 Endocrine/Hormonal Function

The syncytiotrophoblast is a hormonally active tissue producing:

Protein Hormones:

Hormone	Timing	Role
hCG (human chorionic gonadotropin)	Secreted from week 2; peaks at week 8	Maintains corpus luteum, prevents menstruation; basis of pregnancy tests
hCS / hPL (human placental lactogen)	Rises through pregnancy	Decreases maternal glucose utilization → spares glucose for fetus; increases maternal FFA availability
hCT (human chorionic thyrotropin)	Through pregnancy	Functions like TSH

Steroid Hormones:

Hormone	Substrate	Role
Progesterone	Maternal cholesterol	Maintains uterine quiescence; prevents abortion
Estrogens	Fetal adrenal androgens (DHEAS)	Uterine growth, breast development

Clinical note: After the 1st trimester, the placenta takes over progesterone production from the corpus luteum. The fetal-placental-maternal unit (fetoplacental unit) cooperates in estrogen biosynthesis: the fetal adrenal provides the androgen substrate that the placenta aromatizes to estrogens.

4.6 Immunological Function - The Allograft Paradox

The placenta is an allograft - it carries paternal antigens yet is not rejected by the mother. Several mechanisms protect it:

Classical HLA absence: Syncytiotrophoblast does NOT express classical HLA-A or HLA-B antigens that would trigger T-cell recognition
Non-classical HLA expression: Expresses HLA-G and HLA-E, which suppress NK-cell killing
Complement regulation: Expresses complement-regulatory proteins (CD46/membrane cofactor protein) that block C3 activation
IDO (indoleamine 2,3-dioxygenase): In trophoblast cells, depletes tryptophan locally, suppressing T-cell responses
Epigenetic silencing: In decidual stromal cells, T-cell-attracting chemokines are epigenetically silenced (repressive histone marks)
Apoptosis induction: Apoptosis-inducing ligands on trophoblast delete activated maternal leukocytes

Clinical relevance: Failure of these mechanisms may contribute to recurrent miscarriage and preeclampsia.

5. PLACENTAL ABNORMALITIES

5.1 Abnormalities of Implantation (Placenta Accreta Spectrum)

When the decidua is absent (focally or completely), villous tissue contacts or invades myometrium directly:

Term	Definition	Depth
Placenta accreta	Villi abnormally adhere to myometrium (no decidua)	~0.2% of pregnancies
Placenta increta	Villi invade into myometrium	More severe
Placenta percreta	Villi penetrate through the full myometrial wall to serosa or adjacent organs (bladder)	Most severe

Predisposing factors:

Placenta previa (up to 60% of accreta cases)
Previous cesarean section or uterine surgery (endometrial scarring)
Advanced maternal age, multiparity

Presentation: 3rd trimester bleeding, failure of placental separation after delivery → life-threatening postpartum hemorrhage

Management: Planned preterm cesarean hysterectomy, leaving placenta in situ if hysterectomy is not performed (conservative management)

5.2 Placenta Previa

Placenta implants over or adjacent to the internal cervical os
Types: complete (covering os entirely), partial, marginal, low-lying
Presentation: Painless, bright-red vaginal bleeding in the 3rd trimester (classically at 30-32 weeks)
Diagnosis: Ultrasound (transvaginal is most accurate)
Management: Complete placenta previa → cesarean delivery mandatory (vaginal delivery risks catastrophic hemorrhage)

5.3 Placental Abruption (Abruptio Placentae)

Premature separation of a normally implanted placenta from the uterine wall
Presentation: Painful dark vaginal bleeding, rigid ("board-like") uterus, fetal distress
Causes: Hypertension (most common), trauma, cocaine use, thrombophilias, sudden uterine decompression (e.g., after PPROM)
Neonatal consequences: Fetal hypoxia, stillbirth, FGR, neonatal coagulopathy

5.4 Placental Insufficiency and Fetal Growth Restriction (FGR)

During the third trimester, vigorous fetal growth places heavy demands on uteroplacental blood supply. Placental insufficiency is a major cause of FGR:

Causes of uteroplacental insufficiency:

Single umbilical artery and abnormal cord insertion
Placental abruption
Placenta previa
Placental thrombosis and infarction
Chronic villitis of unknown etiology (CVUE)
Placental infection
Multiple gestations

Type of FGR: Placental causes typically produce asymmetric (head-sparing) FGR - body/visceral growth is restricted while brain growth is relatively preserved ("brain-sparing" effect via blood flow redistribution through ductus venosus and foramen ovale).

Neonatal consequences of FGR (SGA infant):

Perinatal asphyxia, hypoglycemia, polycythemia, hypothermia
Increased risk of cerebral dysfunction, learning disability, hearing/visual impairment
Long-term: metabolic syndrome, cardiovascular disease in adult life (Barker hypothesis)

5.5 Placental Infections

Route 1 - Ascending infection (most common):

Bacteria ascend from the birth canal
Cause chorioamnionitis: amniotic fluid becomes cloudy/purulent; chorion-amnion shows maternal neutrophil infiltrate
Premature rupture of membranes (PROM) and preterm labor
Fetal inflammatory response: Vasculitis of umbilical vessels and fetal chorionic plate vessels → intense fetal inflammatory response is associated with neonatal morbidity and cerebral palsy

Route 2 - Hematogenous (transplacental):

From maternal sepsis, viremia, or parasitemia
TORCH organisms (Toxoplasmosis, Others [syphilis, TB, listeriosis], Rubella, CMV, Herpes): cause chronic villitis (chronic inflammatory infiltrate in chorionic villi)
Associated with FGR
CMV causes acute villitis histologically

5.6 Preeclampsia and Eclampsia (Placental Origin)

Caused by inadequate EVT invasion → poorly remodeled spiral arteries → ischemic placenta releases anti-angiogenic factors (especially sFlt-1) and reduced VEGF and PlGF
sFlt-1 causes widespread maternal endothelial dysfunction
Manifestation: New onset hypertension + proteinuria after 20 weeks + systemic features
HELLP syndrome (in ~10% of preeclampsia): Hemolysis + Elevated Liver enzymes + Low Platelets
Eclampsia: Seizures - the most severe manifestation
Responsible for >50,000 maternal deaths yearly worldwide
More common in primigravidas, Black/Hispanic patients, multifetal pregnancies

5.7 Gestational Trophoblastic Disease

Represents the opposite extreme of EVT invasion - excessive invasion
Ranges from hydatidiform mole (benign) → invasive mole → choriocarcinoma (malignant)
hCG is markedly elevated and serves as a tumor marker

5.8 Shape and Structural Abnormalities

Abnormality	Description	Significance
Membranous placenta	Villi persist on entire chorionic sac surface; thin but large	Increased hemorrhage risk
Accessory (succenturiate) lobe	Extra lobe separated from main placenta	Risk: retained lobe after delivery
Bidiscoid placenta	Two lobes	Usually benign
Battledore placenta	Cord inserts at placental margin	Cord compression risk
Velamentous cord insertion	Umbilical vessels travel within fetal membranes before reaching placenta	Risk of vessel rupture and fetal exsanguination (vasa previa)
Circumvallate placenta	Chorionic plate is smaller than basal plate; membrane fold at edge	Associated with abruption, preterm labor

5.9 Single Umbilical Artery (SUA)

Normal cord has 2 arteries + 1 vein
Single umbilical artery found in ~1% of deliveries
Associated with congenital anomalies (cardiac, renal, chromosomal) in ~25-50% of isolated SUA
Warrants fetal echocardiography and detailed anomaly scan

6. THE PLACENTA AND LONG-TERM DISEASE (The Barker Hypothesis)

The placenta links fetal programming to adult disease. Placental insufficiency causing FGR is associated with:

Cardiovascular disease in adult life (hypertension, coronary artery disease)
Type 2 diabetes mellitus
Metabolic syndrome

This forms the basis of the Developmental Origins of Health and Disease (DOHaD) hypothesis - the intrauterine environment programs lifelong metabolic set-points.

CLINICAL SUMMARY TABLE FOR NEONATOLOGISTS

Placental Issue	Neonatal Impact	Immediate Action
Abruption	Asphyxia, anemia, coagulopathy	Cord blood gas, CBC, crossmatch
Placenta previa (C/S)	Anemia, iatrogenic prematurity	Monitor for RDS, anemia
Placental insufficiency / FGR	Hypoglycemia, polycythemia, hypothermia	Dextrose infusion, hematocrit
Chorioamnionitis	Early-onset sepsis, pneumonia, NEC	Cultures, empiric antibiotics
TORCH infections	IUGR, hepatosplenomegaly, CNS injury	Specific serology, ophthalmology
Single umbilical artery	Congenital anomalies	Echo, renal US, chromosomes
Preeclampsia (premature birth)	Prematurity complications, thrombocytopenia	Platelet count, glucose

Key References:

The Developing Human: Clinically Oriented Embryology (Moore & Persaud), Chapter 7
Histology: A Text and Atlas (Ross & Pawlina), Chapter 23
Robbins Pathologic Basis of Disease, Chapters 22 & 10
Creasy & Resnik's Maternal-Fetal Medicine, Chapter on Placenta

Teach me like neonatologist, paeditrcian in depth topic - Tetralogy including caustitive factors for teratogenicity, mode of action of teratogens, critical periods

Finding Sources

Reading File

Loading Image

Reading File

Loading Image

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Loading Image

I now have all the content needed. Let me compile the comprehensive teaching response.

Teratology - Complete Neonatologist/Paediatrician's Teaching Guide

Sources Used

The Developing Human: Clinically Oriented Embryology (Moore & Persaud) - primary source
Robbins & Kumar Basic Pathology
Rosen's Emergency Medicine
The Harriet Lane Handbook (Johns Hopkins, 23rd ed.)

PART 1: TERATOLOGY - FOUNDATIONS

What is a Teratogen?

A teratogen is any agent that can produce a birth defect (congenital anomaly) or increase the incidence of a defect in the population. Environmental factors (drugs, infections, chemicals, radiation) cause 7-10% of all birth defects.

Birth defect causes overall:

Genetic/chromosomal: ~30%
Multifactorial (gene + environment): ~25%
Environmental (teratogens): 7-10%
Unknown: ~50% (most common category)

PART 2: CAUSATIVE FACTORS FOR TERATOGENICITY

2.1 Categories of Teratogens

A. Drugs and Chemicals

The teratogenicity of drugs varies enormously. Some (e.g., thalidomide) cause devastating defects at precise windows of exposure; others cause subtle cognitive or functional deficits with prolonged use throughout gestation. Between 40-90% of women take at least one non-prescription drug during pregnancy, yet less than 2% of birth defects are directly attributable to drugs and chemicals.

Drug / Chemical	Critical Window	Defects Produced
Thalidomide	20-36 days post-fertilization	Phocomelia/amelia (limb reduction), ear anomalies, CHD, gut atresia
Alcohol (ethanol)	Any trimester; no safe amount	FASD: microcephaly, short palpebral fissures, smooth philtrum, thin upper lip, cognitive deficiency, CHD
Isotretinoin (retinoic acid)	Weeks 3-5	Microtia/anotia, depressed nasal bridge, CHD, brain malformations, intellectual disability
Phenytoin	Organogenesis	Fetal hydantoin syndrome: growth deficiency, hypertelorism, flat nasal bridge, cleft lip/palate, digital hypoplasia
Valproate	Organogenesis	High forehead, broad nasal bridge, cardiac defects, neural tube defects (NTD), spina bifida
Warfarin	Weeks 6-12	Nasal hypoplasia, stippled epiphyses, hypoplastic phalanges, brain malformations
Tetracyclines	Week 14 to 8 years postnatal	Tooth enamel hypoplasia, brown/yellow discoloration, impaired long bone growth
Streptomycin	Any	CN VIII damage - deafness and vestibular damage
ACE inhibitors	2nd/3rd trimester	Oligohydramnios, renal tubular dysgenesis, skull ossification defects
Methotrexate	Organogenesis	Microcephaly, micrognathia, low-set ears, growth restriction
DES (diethylstilbestrol)	Prenatal	Vaginal adenosis, clear cell adenocarcinoma (in daughters in 2nd decade); epididymal cysts (in sons)
Cocaine	Any	IUGR, developmental delay, occasional anomalies
Progestins (ethisterone, norethisterone)	Critical period	Cardiovascular defects, hypospadias, VACTERL association

Fetal Alcohol Spectrum Disorder (FASD) - Key Points:

Maternal alcohol abuse is the most common preventable cause of cognitive deficiency
FAS prevalence: 1-2/1000 live births; FASD prevalence: ≥1%
Mechanism: ethanol → acetaldehyde → disrupts cell adhesion, cell migration, apoptosis, and neurotrophic factor signaling
Sentinel facial features: short palpebral fissures, smooth philtrum, thin vermilion border (upper lip), flat nasal bridge, small chin
No safe amount of alcohol during pregnancy - the brain is susceptible throughout gestation

B. Cigarette Smoking

Well-established cause of IUGR (intrauterine growth restriction)
Low birth weight (<2000g) is the chief predictor of infant death
Among heavy smokers, premature delivery is twice as frequent
Mechanism: Nicotine constricts uterine blood vessels → reduced uteroplacental blood flow → ↓O₂ and nutrient delivery. Carboxyhemoglobin (from CO) impairs O₂ transport
Modest increased risk of conotruncal and atrioventricular septal defects
Associated with smaller brain volumes in preterm infants

C. Infectious Agents (Biological Teratogens)

Organism	Route	Key Neonatal Features	Most Sensitive Period
Rubella	Transplacental	Cataracts, CHD (PDA, PS), deafness (classic triad) + cognitive deficiency, glaucoma, microphthalmia	Weeks 1-5 (80% risk); weeks 6-12 (~15%)
CMV	Transplacental (most common congenital viral infection - 1% neonates)	Developmental delay, IUGR, microphthalmia, chorioretinitis, microcephaly, cerebral calcification (periventricular), deafness, cerebral palsy, hepatosplenomegaly	Any (most severe if 1st trimester)
Toxoplasma gondii	Transplacental	Hydrocephalus, intracranial calcification, chorioretinitis (classic triad), IUGR	Any
Treponema pallidum	Transplacental	Bone destruction, CNS damage, skin lesions, saddle nose	After week 16 (treponema)
Herpes simplex	Ascending/transplacental	Skin lesions, encephalitis, eye disease	Peripartum most common
Varicella	Transplacental	Limb hypoplasia, skin scarring, eye defects, brain atrophy	1st-2nd trimester
Zika virus	Transplacental	Microcephaly, brain malformations	1st trimester
HIV	Transplacental/birth/breast milk	IUGR, opportunistic infections	Any

CNS propensity: There is a particular propensity for the CNS to be affected by infectious teratogens. The fetal blood-brain barrier (BBB) offers little resistance to microorganisms.

D. Ionizing Radiation

Exposure to high levels injures embryonic cells → cell death, chromosome breakage, microcephaly, cognitive deficiency, growth restriction
Severity is dose-, rate-, and stage-dependent
Period of greatest CNS sensitivity: 8-16 weeks post-fertilization (peak neuronal proliferation)
25,000 millirads (mrads) is harmful
Diagnostic levels (<10,000 mrads): no conclusive proof of harm
Recommended limit: 500 mrad (0.005 Gy) for entire gestational period
Diagnostic ultrasound: no confirmed harmful effects

E. Maternal Metabolic and Disease States

Condition	Teratogenic Effect
Diabetes mellitus (poorly controlled)	2-3× increased birth defects; macrosomia (fat pads over upper back/lower jaw); sacral agenesis, brain anomalies, skeletal defects, CHD; RDS; neonatal hypoglycemia
Phenylketonuria (PKU)	Maternal hyperphenylalaninemia → cognitive deficiency, microcephaly, CHD, IUGR in offspring
Hypothyroidism	Impaired CNS development (endemic cretinism)
Obesity/hyperthermia	Neural tube defects

F. Chemical/Environmental Teratogens

Agent	Effect
Methylmercury	Cerebral palsy-like picture, deafness, cognitive deficiency (Minamata disease)
Polychlorinated biphenyls (PCBs)	IUGR, skin discoloration (main source: contaminated sport fish)
Lead	Cognitive deficiency, growth restriction

PART 3: PRINCIPLES OF TERATOGENESIS

Three fundamental principles govern teratogenicity (Moore & Persaud):

Critical period of development
Dose of the agent
Genotype (genetic constitution) of the embryo

PART 4: MODES OF ACTION OF TERATOGENS

4.1 Cellular Mechanisms

Teratogens act through one or more of these cellular pathways:

Mechanism	Explanation	Example
Cell death (apoptosis)	Programmed or pathological cell death during organogenesis	Thalidomide - induces apoptosis in limb bud cells via anti-angiogenic effects and Wnt/IGF signaling disruption
Faulty cellular interaction/induction	Disruption of cell signaling between adjacent tissues (paracrine induction)	Retinoic acid - disrupts HOX gene expression domains
Reduced biosynthesis of substrates	Impairs synthesis of structural proteins, enzymes, neurotransmitters	Folate antagonists - disrupt nucleotide synthesis → NTDs
Impaired morphogenetic movements	Cells fail to migrate correctly (e.g., neural crest cell migration)	Isotretinoin blocks neural crest cell migration
Altered gene expression	Disruption of transcription factor cascades (HOX, PAX, NKX genes)	Valproate inhibits histone deacetylase → altered gene expression
Mechanical disruption	Physical forces	Amniotic bands, oligohydramnios
Impaired DNA repair	Radiation, alkylating agents	Ionizing radiation - DNA double-strand breaks
Anti-angiogenesis	Disrupted blood vessel formation in embryo	Thalidomide (anti-VEGF)

4.2 Molecular Pathways Disrupted

Retinoic acid (RA) pathway: RA regulates HOX gene expression determining anterior-posterior body patterning. Excess RA from isotretinoin massively upregulates retinoic acid receptors → reprograms HOX boundaries → craniofacial and limb malformations
Sonic Hedgehog (SHH) pathway: SHH is critical for CNS septation, limb patterning, gut development. Cyclopamine (plant alkaloid) blocks SHH → cyclopia and holoprosencephaly. Defects in cholesterol biosynthesis (e.g., Smith-Lemli-Opitz syndrome) impair SHH signaling because SHH requires cholesterol modification for activation
WNT pathway: Disruption affects neural crest cell fate and cardiac septation
Folate-dependent methylation: Folate deficiency → impaired DNA synthesis and methylation → neural tube defects. Supplementation with 400-800 mcg/day prevents up to 70% of NTDs
Common final pathway: Different teratogens act through different initial mechanisms but converge on a common downstream pathway → intrauterine death, developmental defects, FGR, or functional disturbances

4.3 The "All-or-Nothing" Principle (Weeks 1-2)

During the first 2 weeks post-fertilization (pre-embryonic period), teratogens either:

Kill the embryo (all-or-nothing effect), OR
Their disruptive effects are completely compensated by the powerful regulatory properties of the early embryo (totipotency of blastomeres)

Birth defects are NOT produced during weeks 1-2 even if the embryo survives.

PART 5: CRITICAL PERIODS OF HUMAN DEVELOPMENT

This is the most clinically important concept in teratology.

Risk of birth defects versus weeks of human development - the bell curve of teratogenic susceptibility

Key principle: The embryo's stage of development when it encounters a teratogen determines susceptibility. The most critical period is when cell division, cell differentiation, and morphogenesis are at their peak.

Critical Period Timeline

Period	Weeks Post-Fertilization	What Happens	Teratogen Effect
Pre-embryonic	Weeks 1-2	Cleavage, implantation	Death OR no effect (all-or-nothing)
Embryonic (peak sensitivity)	Weeks 3-8	Organogenesis - all major organ systems form	Major structural malformations
Early fetal	Weeks 9-16	Organ growth and differentiation	Physiologic defects, minor morphologic defects, beginning of functional disruption
Mid to late fetal	Weeks 17-38	Growth and maturation	Functional disturbances (cognitive deficiency, behavioral) - no major structural defects after organogenesis

Organ-Specific Critical Periods

Organ/System	Critical Period	Teratogen Timing Matters
Central nervous system	Weeks 3-16 (brain continues to week 16+, always sensitive)	Any teratogen active 3-16 weeks can cause cognitive deficiency; severe structural defects 3-8 weeks
Heart	Weeks 3-8	Heart defects caused only during this window; heart accounts for 8/1000 birth defects
Eyes	Weeks 4-8	Cataracts, microphthalmia (rubella in week 4-6)
Limbs	Weeks 4-8	Thalidomide days 20-36; limb reduction defects only if teratogen acts before end of limb critical period
Ears	Weeks 4-10	Internal ear: 4-8 weeks; external ear: longer
Palate	Weeks 6-10	Cleft palate from phenytoin, corticosteroids
Brain	Weeks 3-16 and beyond	8-16 weeks is most sensitive for radiation cognitive damage (peak neuronal proliferation)
Teeth	Week 14 through 8 years postnatal	Tetracycline can damage both primary and permanent teeth over prolonged window
Skeleton	Prolonged, into childhood
Genitalia	Weeks 7-14	Androgens, DES; male genital tract DES effect before week 11

Incidence of major birth defects by organ (at birth):

Brain: 10/1000
Heart: 8/1000
Kidneys: 4/1000
Limbs: 2/1000
Other: 6/1000
Total: ~30/1000 (3%)

Important Corollary

"Because biochemical differentiation precedes morphologic differentiation, the period during which structures are sensitive to interference by teratogens often precedes the stage of their visible development by a few days." - Moore & Persaud

This means teratogenic damage can occur before the organ is even morphologically visible - a critical fact for advising pregnant patients about early drug exposures.

PART 6: TETRALOGY OF FALLOT (ToF)

6.1 Definition and Anatomy

Tetralogy of Fallot is the most common cyanotic congenital heart disease beyond infancy, accounting for approximately 5% of all congenital cardiac malformations.

The four cardinal features:

Right ventricular outflow tract obstruction (RVOTO) - subpulmonic (infundibular) stenosis is most common; can also be at valvular level or complete atresia
Large, unrestrictive VSD - typically perimembranous, in the vicinity of the membranous interventricular septum
Overriding aorta - aortic valve lies immediately over the VSD, receiving blood from both ventricles
Right ventricular hypertrophy - secondary to high pressure load from RVOTO

Tetralogy of Fallot - right-to-left shunting through VSD with overriding aorta (OAo), outflow obstruction (OB)

6.2 Embryological Basis

All four features result from a single embryologic defect: anterosuperior displacement of the infundibular (conal/outlet) septum during cardiac development.

This leads to abnormal septation between the pulmonary trunk and aortic root
The pulmonary trunk becomes small/hypoplastic
The aorta overrides the malaligned VSD
Right ventricular hypertrophy is secondary to RVOTO

Extreme form: Pulmonary atresia with VSD - entire right ventricular output goes through the aorta; pulmonary blood flow depends entirely on PDA or bronchial collateral vessels.

6.3 Gross Pathology

Heart is enlarged and "boot-shaped" (coeur en sabot) - due to RV hypertrophy
Proximal aorta: dilated
Pulmonary trunk: hypoplastic
RV wall: markedly hypertrophied (can exceed LV thickness)
VSD: large, near membranous septum
Left-sided chambers: normal size (important - distinguishes from other cyanotic lesions)

6.4 Hemodynamics and Clinical Presentation

The key clinical determinant is the degree of RVOTO:

RVOTO Severity	Hemodynamics	Clinical Picture
Mild ("Pink Tet")	Left-to-right shunt predominates (high left pressure overcomes)	Acyanotic, acts like isolated VSD
Moderate	Bidirectional shunting	Mild cyanosis, progressive
Severe	Right-to-left shunt predominates	Profound cyanosis within first days of life; PGE1 dependent

Physical Examination:

Varying degrees of cyanosis
Systolic ejection murmur along the left sternal border (from RVOTO, not VSD - the VSD is silent because it is large and non-restrictive)
With pulmonary atresia: no murmur (no flow through RVOT), continuous murmur from PDA or collaterals
Chronic hypoxemia → compensatory polycythemia and clubbing of fingers and toes

Investigations:

CXR: Decreased pulmonary vascular markings ("black lung fields") + boot-shaped heart (concave main pulmonary artery segment on left heart border) + right-sided aortic arch in 25%
ECG: Right ventricular hypertrophy + right axis deviation
Echo: Diagnostic - shows RVOTO, VSD, overriding aorta, RVH; measures gradients

6.5 The Tet Spell (Hypercyanotic/Hypoxic Spell)

Peak incidence: 2-4 months of age

Trigger: Any event that suddenly lowers systemic vascular resistance (SVR) - crying, defecation, agitation, feeding, fever, hypovolemia, tachycardia

Vicious cycle:

↓SVR → ↑Right-to-left shunt across VSD → ↓PaO₂, ↑PCO₂, ↓pH → stimulates respiratory center → hyperpnea → ↑negative intrathoracic pressure → ↑venous return to RV → ↑volume shunted right-to-left → worsening hypoxia → deeper hyperpnea → cycle repeats

Clinical features: Hyperpnea, prolonged crying, increasing cyanosis, limpness → possible syncope, seizure, stroke, or death if untreated

Management of Tet Spell (Harriet Lane / Rosen's):

Step	Intervention	Mechanism
1st	Knee-to-chest position	↑ SVR + ↓ venous return → ↓ right-to-left shunt
2nd	Supplemental O₂	Limited value alone; provides some pulmonary vasodilation
3rd	Morphine 0.1-0.2 mg/kg IV/IM	Suppresses respiratory center → breaks hyperpnea cycle; reduces SVR and tachycardia
Alt	Fentanyl 1 mcg/kg IV/IM (or 1.5-2 mcg/kg intranasal)	Same as morphine
Alt	Midazolam 0.2-0.3 mg/kg intranasal	Anxiolysis, reduces crying
4th	NaHCO₃ 1 mEq/kg IV	Corrects metabolic acidosis
5th	Ketamine 1-2 mg/kg IV / 3-5 mg/kg IM	↑ SVR + sedation
6th	Propranolol 0.1-0.2 mg/kg IV	↓ HR, relaxes infundibular spasm
7th	Phenylephrine 0.01-0.02 mg/kg IV	Directly ↑ SVR → reverses shunt direction

6.6 Associations

Right-sided aortic arch (25%)
ASD (in some - "Pentalogy of Fallot")
Anomalous origin of left coronary artery
Genetic: ~15% have 22q11.2 deletion (DiGeorge/velocardiofacial syndrome) - screen all ToF patients
Down syndrome (trisomy 21)

6.7 Management

Neonatal/Infant:

Severe/duct-dependent ToF: PGE1 (prostaglandin E1) infusion to maintain PDA
Tet spells: managed as above
Oral propranolol: for preventing tet spells while awaiting surgery

Surgical:

Complete intracardiac repair (preferred in early infancy, typically 3-6 months): VSD patch closure + relief of RVOTO (infundibular resection ± transannular patch)
Palliative shunt (if anatomy not suitable for primary repair): Blalock-Taussig-Thomas (BTT) shunt - subclavian artery to pulmonary artery

Long-term issues post-repair:

Pulmonary regurgitation (after transannular patch) → RV dilation → arrhythmia, RV failure → may need pulmonary valve replacement in 2nd-3rd decade
Residual RVOT gradient
Ventricular arrhythmias (risk of sudden cardiac death - follow with Holter monitoring)

SUMMARY - THE BIG PICTURE

Teratology = Study of abnormal development

TERATOGEN acts during CRITICAL PERIOD
↓
Mode of action:
  - Cell death
  - Disrupted induction
  - Altered gene expression (HOX, SHH, WNT)
  - Impaired cell migration
  - Mechanical disruption
↓
Outcome depends on:
  1. Timing (critical period of organ)
  2. Dose
  3. Fetal genotype
↓
WEEK 1-2: all-or-nothing (death or no defect)
WEEK 3-8: MAJOR MALFORMATIONS (peak risk)
WEEK 9-16: minor morphologic + beginning functional deficits
WEEK 17-38: FUNCTIONAL deficits only (cognitive, behavioral)

Tetralogy of Fallot = single embryologic defect (infundibular septal malalignment during cardiac organogenesis, weeks 3-7) → 4 anatomic consequences → right-to-left shunt → cyanosis → tet spells → repair in infancy → excellent long-term survival with follow-up.

The Developing Human: Clinically Oriented Embryology, Chapter 20
Robbins & Kumar Basic Pathology, Chapter 9
Rosen's Emergency Medicine, Chapter 165
The Harriet Lane Handbook, Chapter 13

This is a shared conversation. Sign in to Orris to start your own chat.